Furthermore, AhR was found to be a direct repressor of the expression of Oct-4 in glioblastoma cancer stem cells, where treatment with the tryptophan derivative ITE promoted the differentiation of GBM CSC and suppressed the growth of GBM xenografts [88]. Here, POU5F1 is linked to cancer.